RPLS with Acute Hypertension: What to Do When First-Line Antihypertensive Agents Have Not Achieved Blood Pressure Targets
In reversible posterior leukoencephalopathy syndrome with acute hypertension, management begins with first-line continuous intravenous antihypertensive agents alongside supportive measures. When that initial step fails to bring blood pressure within the required range, a defined escalation protocol takes over.
Initial therapy with first-line continuous intravenous antihypertensive agents — including labetalol, nicardipine, or nimodipine — did not achieve the required blood pressure targets: a gradual reduction of no more than 20–25% within the first few hours, with a mean arterial pressure between 105 and 125 mm Hg.
The blood pressure goals remain unchanged for this escalation step: reduce blood pressure gradually by no more than 20–25% in the first few hours, aiming for a mean arterial pressure of 105–125 mm Hg. Continuous intravenous administration is typically required to sustain this control.
This protocol escalates to second-line intravenous antihypertensive agents. Agent selection, specific dosing guidance, sequencing, and monitoring parameters are detailed in the full structured regimen below.